Live Breaking News & Updates on Statistically Funny
Stay updated with breaking news from Statistically funny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Absolutely Maybe It’s been another drama-filled, and data-packed, hectic few weeks in the Covid vaccines landscape. But the visual theme of this roundup post is the gigantic global airlift that’s underway at last, and the relief and hope that comes with it. There are the usual updates on the vaccines that have released efficacy results – and all the phase 3 trials that are underway, with over 460,000 participants so far. I’ve highlighted major community studies, too, the developments in combinations of vaccines, and trials in children and in pregnancy. And if after all that, you’d still like to read more, I wrote about why differences between vaccines matter ....
Variants, 3 New Covid Vaccines, and Contested Efficacy Claims: A Month of Seismic Shifts and Confusion plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.
Absolutely Maybe We’re into the 12th month since sequencing of the genome of SARS-Cov-2, the virus that causes Covid-19. And we have 2 Covid vaccines across the line of convincing phase 3 trial results released, plus emergency use authorization or approval. How far are we now, and why did some sprint ahead while others fell behind? Let’s start with what we know from the handful of vaccines with at least some data released. Main takeaways about Covid vaccines so far There are important, often major, differences in the characteristics and effects of the vaccines. 2 vaccines have been convincingly shown to have high efficacy against getting sick with Covid-19 – BNT/Pfizer’s and NIH/Moderna’s. ....